Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European ...
What is Tracleer® (bosentan)?. Tracleer is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group ...
Easy to read patient leaflet for bosentan. Includes indications, proper use, special instructions, precautions, and possible side effects.
Mar 15, 2017 ... Bosentan: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Learn about Tracleer (Bosentan) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Medscape - Indication-specific dosing for Tracleer (bosentan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...
What is bosentan? Bosentan is an oral medication classified as an endothelin receptor antagonist (ERA) which is approved for the treatment of pulmonary ...
Find patient medical information for bosentan oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Consumer information about the medication BOSENTAN - ORAL (Tracleer), includes side effects, drug interactions, recommended dosages, and storage ...
Jun 13, 2005 ... Bosentan is metabolized in the liver by the cytochrome P450 enzymes CYP2C9 and CYP3A4 (and possibly CYP2C19), producing three ...